Deracemization of (±)-2,3-disubstituted oxiranes via biocatalytic hydrolysis using bacterial epoxide hydrolases: kinetics of an enantioconvergent process

(Note: The full text of this document is currently only available in the PDF Version )

Wolfgang Kroutil, Martin Mischitz and Kurt Faber


Abstract

Asymmetric biocatalytic hydrolysis of (±)-2,3-disubstituted oxiranes leading to the formation of vicinal diols in up to 97% ee at 100% conversion was accomplished by using the epoxide hydrolase activity of various bacterial strains. The mechanism of this deracemization was elucidated by 18OH2-labelling experiments using a partially purified epoxide hydrolase from Nocardia EH1. The reaction was shown to proceed in an enantioconvergent fashion by attack of OH at the (S)-configured oxirane carbon atom with concomitant inversion of configuration. A mathematical model developed for the description of the kinetics was verified by the determination of the four relative rate constants governing the regio- and enantio-selectivity of the process.


References

  1. H. C. Kolb, M. S. VanNieuwenhze and K. B. Sharpless, Chem. Rev., 1994, 94, 2483 CrossRef CAS.
  2. V. Schurig and F. Betschinger, Chem. Rev., 1992, 92, 873 CrossRef CAS.
  3. R. A. Johnson and K. B. Sharpless, in Catalytic Asymmetric Synthesis, ed. I. Ojima, Verlag Chemie, New York, 1993, p. 103 Search PubMed; E. N. Jacobsen, W. Zhang, A. R. Muci, J. R. Ecker and L. Deng, J. Am. Chem. Soc., 1991, 113, 7063 Search PubMed; K. Konishi, K. Oda, K. Nishida, T. Aida and S. Inoue, J. Am. Chem. Soc., 1992, 114, 1313 CrossRef CAS.
  4. J. A. M. de Bont, Tetrahedron: Asymmetry, 1993, 4, 1331 CrossRef CAS; D. J. Leak, P. J. Aikens and M. Seyed-Mahmoudian, Trends Biotechnol., 1992, 10, 256 CrossRef CAS; A. N. Onumonu, A. Colocoussi, C. Matthews, M. P. Woodland and D. J. Leak, Biocatalysis, 1994, 10, 211 Search PubMed; P. Besse and H. Veschambre, Tetrahedron, 1994, 50, 8885 CrossRef CAS; S. Pedragosa-Moreau, A. Archelas and R. Furstoss, Bull. Soc. Chim. Fr., 1995, 132, 769 CAS.
  5. F. Oesch, Xenobiotica, 1972, 3, 305.
  6. S. Pedragosa-Moreau, A. Archelas and R. Furstoss, Tetrahedron, 1996, 52, 4593 CrossRef CAS.
  7. S. Pedragosa-Moreau, A. Archelas and R. Furstoss, J. Org. Chem., 1993, 58, 5533 CrossRef CAS.
  8. (a) M. Mischitz, W. Kroutil, U. Wandel and K. Faber, Tetrahedron: Asymmetry, 1995, 6, 1261 CrossRef CAS; (b) I. Osprian, W. Kroutil, M. Mischitz and K. Faber, Tetrahedron: Asymmetry, 1997, 8, 65 CrossRef CAS.
  9. (a) For a review see: K. Faber, M. Mischitz and W. Kroutil, Acta Chem. Scand., 1996, 50, 249 Search PubMed; (b) For the isolation and characterization of a highly selective bacterial epoxide hydrolase see: M. Mischitz, K. Faber and A. Willetts, Biotechnol. Lett., 1995, 17, 893 Search PubMed.
  10. M. Mischitz, C. Mirtl, R. Saf and K. Faber, Tetrahedron: Asymmetry, 1996, 7, 2041 CrossRef CAS.
  11. C.-S. Chen, Y. Fujimoto, G. Girdaukas and C. J. Sih, J. Am. Chem. Soc., 1982, 104, 7294 CrossRef CAS.
  12. For a preliminary communication see: W. Kroutil, M. Mischitz, P. Plachota and K. Faber, Tetrahedron Lett., 1996, 37, 8379 Search PubMed.
  13. W. Kroutil, I. Osprian, M. Mischitz and K. Faber, Synthesis, 1997, 156 CrossRef CAS.
  14. G. M. Lacourciere and R. N. Armstrong, J. Am. Chem. Soc., 1993, 115, 10 466 CrossRef CAS; B. D. Hammock, F. Pinot, J. K. Beetham, D. F. Grant, M. E. Arand and F. Oesch, Biochem. Biophys. Res. Commun., 1994, 198, 850 CrossRef CAS; M. Arand, H. Wagner and F. Oesch, J. Biol. Chem., 1996, 271, 4223 CrossRef CAS.
  15. Obtained via OsO4-dihydroxylation of the corresponding Z- and E- alkene.
  16. For reasons of clarity, the following nomenclature is used throughout this paper: epoxide and diol enantiomers are denoted as A/B and P/Q, respectively; the position of the oxygen incorporation in diols P and Q (as determined by 18O-labelling experiments) is indicated by subscript arabic numerals.
  17. Full details of the isolation and characterization of the epoxide hydrolase from Nocardia EH1 will be reported elsewhere. Preliminary data indicate that the enzyme is related to the epoxide hydrolase from Rhodococcus sp. NCIMB 11216, i.e. a constitutive, soluble protein having a relative molecular mass of ∼35 kDa. See ref. 9b.
  18. A related approach was elaborated by Kagan and co-workers, which allows the determination of the quotients k1/k2 and k3/k4, whereas other quotients of kis can only be determined for t approaching zero. As a consequence, preparatively useful applications cannot be sufficiently treated. By using our approach, all quotients of kis can be determined at any ti during the whole course of the reaction. See: S. El-Baba, J.-C. Poulin and H. B. Kagan, Tetrahedron, 1984, 40, 4275 Search PubMed.
  19. The absence of spontaneous hydrolysis under the reaction conditions employed was verified using blank-experiments in the absence of biocatalyst. No trace of hydrolysis was observed within ∼600 h.
  20. The GLC/MS data from the 18O-experiments had to be subjected to background correction for the following reason: the fragmentation pattern of (unlabelled) heptane-2,3-diol shows not only a major peak with m/z 87, but also a minor signal with m/z 85 which corresponds to [(m/z)– 2 H]. Since the major m/z-peak from the 16O-fragment (87) coincides with the minor [(m/z)– 2 H] signal from the 18O-fragment (87), this signal was subjected to background correction by comparison with the spectra obtained from unlabelled material. The corrected values thus obtained accurately describe the regioselectivity of the 18O-incorporation. Since the MS data obtained correspond to the average of scans, but not absolute values, the peak integration values were corrected with an additional factor (f)via calibration with the (absolute) values from the enantiomeric composition obtained via GLC. PGC, QGC correspond to amounts measured by areas, whereas PMS, QMS stand for amounts via average counts. f=(QGC·PMS/PGC·QMS).
  21. Since the starting material is racemic, A0 equals B0.
  22. E corresponds to the quotient of the reaction rates of the two enantiomers (k3+k4/k1+k2).
  23. G. Bellucci, G. Berti, G. Catelani and E. Mastrorilli, J. Org. Chem., 1981, 46, 5148 CrossRef CAS.
  24. G. Bellucci, C. Chiappe and A. Cordoni, Tetrahedron: Asymmetry, 1996, 7, 197 CrossRef CAS.
  25. E. Blée and F. Schuber, Eur. J. Biochem., 1995, 230, 229 CAS.
  26. Obtained via transesterification of commercially available tert-butyl (R)-2-hydroxybutanoate using catalytic NaOEt in ethanol (room temp.; 24 h).
Click here to see how this site uses Cookies. View our privacy policy here.